We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.77B
AUM Growth
+$5.62M
Cap. Flow
-$44.6M
Cap. Flow %
-2.52%
Top 10 Hldgs %
41.79%
Holding
238
New
7
Increased
36
Reduced
104
Closed
6

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$75.9M
2
ABNB icon
Airbnb
ABNB
+$7.32M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.48M
4
GTLB icon
GitLab
GTLB
+$2.35M
5
ECL icon
Ecolab
ECL
+$2.29M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$28M
2
CSCO icon
Cisco
CSCO
+$14.8M
3
TRV icon
Travelers Companies
TRV
+$12.2M
4
AAPL icon
Apple
AAPL
+$9.09M
5
COF icon
Capital One
COF
+$8.61M

Sector Composition

Rank Sector Weight
1 Technology 27.76%
2 Consumer Staples 15.54%
3 Financials 15.11%
4 Healthcare 10.25%
5 Consumer Discretionary 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
126
Phillips 66
PSX
$82.5B
$1.35M 0.08%
10,239
D icon
127
Dominion Energy
D
$60.7B
$1.27M 0.07%
21,078
+700
+3% +$38.2K
NKE icon
128
Nike
NKE
$61.6B
$1.17M 0.07%
14,355
-11,592
-45% -$909K
EFX icon
129
Equifax
EFX
$20.6B
$1.17M 0.07%
4,250
-315
-7% -$88.8K
TT icon
130
Trane Technologies
TT
$104B
$1.13M 0.06%
2,815
-85
-3% -$29.5K
BLK icon
131
Blackrock
BLK
$176B
$1.12M 0.06%
1,116
BA icon
132
Boeing
BA
$187B
$1.11M 0.06%
6,975
-1
-0% -$171
MSTR icon
133
Strategy Inc
MSTR
$35.4B
$1.1M 0.06%
5,000
NVO
134
Novo Nordisk
NVO
$195B
$1.06M 0.06%
9,000
-400
-4% -$53.3K
CTVA icon
135
Corteva
CTVA
$51.6B
$1.05M 0.06%
17,759
-7,110
-29% -$388K
IWR icon
136
iShares Russell Mid-Cap ETF
IWR
$57.3B
$1.04M 0.06%
11,600
AZN icon
137
AstraZeneca
AZN
$241B
$1.01M 0.06%
6,513
PGR icon
138
Progressive
PGR
$122B
$1M 0.06%
4,000
NFLX icon
139
Netflix
NFLX
$304B
$1,000K 0.06%
13,000
-900
-6% -$60.2K
NUE icon
140
Nucor
NUE
$62B
$995K 0.06%
6,369
PNC icon
141
PNC Financial Services
PNC
$102B
$995K 0.06%
5,362
-454
-8% -$79.6K
EW icon
142
Edwards Lifesciences
EW
$51.2B
$973K 0.05%
13,911
A icon
143
Agilent Technologies
A
$39.3B
$954K 0.05%
7,000
SCHW
144
Charles Schwab
SCHW
$185B
$943K 0.05%
13,300
-25,500
-66% -$1.68M
UBS icon
145
UBS Group
UBS
$176B
$937K 0.05%
29,000
ZTS icon
146
Zoetis
ZTS
$31.8B
$930K 0.05%
4,900
VZ icon
147
Verizon
VZ
$195B
$898K 0.05%
20,550
+8,150
+66% +$340K
FMC icon
148
FMC
FMC
$1.3B
$896K 0.05%
14,448
DUK icon
149
Duke Energy
DUK
$97.2B
$884K 0.05%
7,357
-6,082
-45% -$677K
MCHP icon
150
Microchip Technology
MCHP
$43.7B
$868K 0.05%
11,600

Similar funds

Cullinan Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Cullinan Associates held 238 positions worth $1.77B, up 0.32% from $1.77B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Cullinan Associates's Q3 2024 filing shows 7 new, 36 increased, 104 reduced and 6 closed positions. Its largest new stake was GitLab: 47,000 shares worth $2.61M. The largest sale was Walmart Inc, an estimated $28M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Consumer Staples and Financials.

  • Cullinan Associates's largest Q3 2024 buy was GitLab: 47,000 shares worth $2.61M.
  • Cullinan Associates added most to Lam Research in Q3 2024, an estimated $75.9M increase.
  • Cullinan Associates's biggest Q3 2024 reduction was Walmart Inc, cutting an estimated $28M.
  • Cullinan Associates fully exited Capital One in Q3 2024, selling an estimated $8.61M.
  • Cullinan Associates's ten largest holdings make up 42% of its $1.77B portfolio in Q3 2024.
  • Cullinan Associates opened 7 new positions and closed 6 in Q3 2024.
  • Cullinan Associates's portfolio value rose 0.32% quarter-over-quarter to $1.77B.

Based on Cullinan Associates's 13F filing for Q3 2024, filed 23 Oct 2024.